ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

NCI Awards Grants To Physicians For Cancer Detection

August 2, 1991

Bass & Howes Bought By DDB Seattle

March 22, 2002

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014